e.g. Tata motors, Reliance MF, 500570

Bliss GVS Pharma Ltd. - Research Center

506197 BLISSGVS Group (T) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 26 Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22
Income
Operating income 729.81 667.20 605.46 598.34 636.36
Expenses
Material consumed 342.64 346.11 299.47 314.90 343.94
Manufacturing expenses 12.95 9.76 8.81 5.80 7.09
Personnel expenses 121.50 99.42 82.59 72.54 65.06
Selling expenses 1.67 1.61 0.99 0.50 0.14
Adminstrative expenses 117.02 118.73 106.43 114.45 110.92
Expenses capitalised - - - - -
Cost of sales 595.77 575.62 498.29 508.18 527.16
Operating profit 134.03 91.59 107.17 90.16 109.20
Other recurring income 43.72 36.22 33.50 50.77 32.63
Adjusted PBDIT 177.75 127.80 140.67 140.92 141.83
Financial expenses 11.11 6.58 5.81 10.06 4.32
Depreciation 31.02 27.05 23.52 15.17 13.85
Other write offs - - - - -
Adjusted PBT 135.62 94.17 111.34 115.69 123.66
Tax charges 36.59 25.20 19.61 30.21 33.74
Adjusted PAT 99.03 68.97 91.73 85.48 89.92
Non recurring items -2.34 -0.56 -41.24 -0.67 3.05
Other non cash adjustments - - - - -
Reported net profit 96.69 68.41 50.49 84.81 92.97
Earnigs before appropriation 1,053.56 960.98 896.67 850.15 769.19
Equity dividend 10.56 5.25 5.21 5.19 5.18
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 1,042.99 955.74 891.46 844.96 764.02
Close
Add Bliss GVS Pharma Ltd. to your Portfolio
 
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Bliss GVS Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback